Ondansetron Solution
Product Images NDC 65862-208

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 65862-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg/5 mL (50 mL Bottle))

Label for Ondansetron Oral Solution USP 4 mg/5 mL, a 50 mL oral solution containing ondansetron hydrochloride (dihydrate) equivalent to 4 mg ondansetron base per 5 mL. Distributed by Aurobindo Pharma USA, Inc., the label includes storage instructions, dosage note, and barcode. Manufactured in India by Aurobindo Pharma Limited.*

FDA Label Image

Package Label-principal Display Panel (4 mg/5 mL Container Carton)

Packaging label for Ondansetron Oral Solution, USP 4 mg/5 mL, a 50 mL oral solution by Aurobindo Pharma Limited. The label includes active ingredient details, storage instructions, dosage reference, and distribution information by Aurobindo Pharma USA, Inc. It features the product name and strength prominently in green, along with Rx only designation and barcode.*

FDA Label Image

Chemical Structure (Ondansetron Str)

Chemical structure of Ondansetron Hydrochloride dihydrate, showing its molecular framework including indole and imidazole rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.